• A Case of Primary Biliary Cholangitis in a Patient With Multiple Sclerosis
• A Rare Case of Life-Threatening Hemorrhage
• Acquired ductopenia: an insight into imaging findings
• Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier
• ALKALINE PHOSPHATASE AND LIVER FIBROSIS AT DIAGNOSIS ARE ASSOCIATED WITH DEEP RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS
• An analysis of related factors in thrombocytopenia combined with cirrhosis: a cross-sectional study of 2 517 cases
• An insight into the epidemiology of foodborne zoonotic fascioliasis in small ruminants in northwestern region of Bangladesh
• An Unusual Cause of Hilar Biliary Obstruction
• Animal and organoid models to elucidate the anti-fibrotic effect of steroid on biliary atresia
• Arrival-Time Parametric Imaging in Contrast-Enhanced Ultrasound for Diagnosing Fibrosis in Primary Biliary Cholangitis: Erratum
• Assessment of the utility of two-dimensional shear wave elastography and superb microvascular imaging in postoperative patients with biliary atresia
• Association between Metabolic-Dysfunction-Associated Steatotic Liver Disease and Hepatic Cancer: Current Concepts and Future Challenges
• Association between primary biliary cholangitis with diabetes and cardiovascular diseases: A bidirectional multivariable Mendelian randomization study
• Autoimmune diseases and COPD risk: A Mendelian randomization study
• Biliary atresia in a 3-month-old infant (case report)
• Biliary atresia-splenic malformation (BASM) syndrome: A case report
• Biliary atresia: the role of gut microbiome, and microbial metabolites
• Biliary Cirrhosis associated with WDR19-Related Ciliopathy in Siblings
• Bleeding Complications of Portal Hypertension
• Burden of digestive system diseases in China and its provinces during 1990-2019: Results of the 2019 Global Disease Burden Study
• Causal effects of autoimmune diseases on temporomandibular disorders and the mediating pathways: a Mendelian randomization study
• Causal effects of autoimmune diseases on thyroid cancer: a two-sample Mendelian randomization study
• Circulating bacterial peptides and linked metabolomic signatures are indicative of early mortality in pediatric cirrhosis
• Clinical Characteristics of Primary Biliary Cirrhosis - Idiopathic Inflammatory Myopathy Overlap Syndrome: a Single Center Study
• Clinical significances of several fibrotic markers for prognosis in hepatocellular carcinoma patients who underwent hepatectomy
• Clonorchis sinensis aggravated liver fibrosis by activating PARP-1 signaling to induce parthanatos via DNA damage
• Combination of carvedilol with variceal band ligation in prevention of first variceal bleed in Child-Turcotte-Pugh B and C cirrhosis with high-risk oesophageal varices: the 'CAVARLY TRIAL'
• Combination of Pirfenidone and Andrographolide Ameliorates Hepatic Stellate Cell Activation and Liver Fibrosis by Mediating TGF-beta/Smad Signaling Pathway
• Comparison of Mir122 expression in children with biliary atresia and healthy group
• Complete Match of Streptococcus salivarius from Oral Saliva and Stool in a Patient with Hepatic Encephalopathy
• Comprehensive analysis of adverse events associated with transmural use of LAMS in patients with liver cirrhosis: International multicenter study
• Depressive symptom as a risk factor for cirrhosis in patients with primary biliary cholangitis: Analysis based on Lasso-logistic regression and decision tree models
• Determining the association between systematic lupus erythematosus and the occurrence of primary biliary cirrhosis: a systematic review and meta-analysis
• Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis
• Diagnostic Accuracy of Transient Elastography for Staging Liver Fibrosis in Autoimmune Liver Diseases: A Systematic Review and Meta-Analysis
• Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis
• Effect of midodrine on HVPG in advanced chronic liver disease and acute-on-chronic liver failure-A pilot study
• Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease
• Eicosapentaenoic acid administration ameliorates the progression of liver fibrosis after laparoscopic Kasai portoenterostomy
• Elastography-The New Standard in the Assessment of Fibrosis After Pediatric Liver Transplantation?
• Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease
• Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis
• Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis
• Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients
• Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study
• Full Robotic Whole Graft Liver Transplantation: A Step Into The Future
• Gallbladder dysfunction caused by MYPT1 ablation triggers cholestasis-induced hepatic fibrosis in mice
• Genomic landscape of hepatocellular carcinoma in Egyptian patients by whole exome sequencing
• Glomerulonephritis in primary biliary cholangitis in China: an important complication
• Hemothorax caused by injury of musculophrenic artery after ultrasound-guided percutaneous liver biopsy: a case report
• High C-reactive protein-to-albumin ratio levels are associated with osteoporosis in patients with primary biliary cholangitis
• High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis
• Identification of microbial antigens in liver tissues involved in the pathogenesis of primary biliary cholangitis using 16S rRNA metagenome analysis
• Impact of coagulopathy assessment with thromboelastography and thromboelastometry on transfusion requirements in critically ill cirrhosis with nonvariceal bleeding: A prospective observational study
• Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in MAFLD-Related Acute-on-Chronic Liver Failure
• Impact of educational interventions on hepatitis B and C awareness among school students of Delhi NCR, India
• Inborn Errors of Immunity in Adults with Autoimmune Liver Diseases
• Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan
• Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
• KDM4C represses liver fibrosis by regulating H3K9me3 methylation of ALKBH5 and m6A methylation of snail1 mRNA
• Laparoscopic liver resection for a patient of hepatocellular carcinoma with von Willebrand disease: a case report
• Liver Disease as a Potential Risk Factor for Colorectal Cancer: A Community Hospital Experience
• Long-term outcomes in patients with primary biliary cholangitis complicated with CREST syndrome
• Management of liver disease and portal hypertension in cystic fibrosis: a review
• Multidrug-resistant bacterial infections in the liver transplant setting
• Obstructive sleep apnea and 19 gastrointestinal diseases: a Mendelian randomization study
• Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis
• PERCUTANEOUS CHOLANGIOSCOPY AND LASER BILIARY LITHOTRIPSY FOR BILIARY INTRAHEPATIC STONES MANAGEMENT: CASE REPORT
• Performance of Baveno VII criteria for the screening of varices needing treatment in patients with biliary atresia
• Plasma Exchange for Refractory Pruritus Due to Drug-Induced Chronic Cholestasis Following Azithromycin Misuse in COVID-19 Infection
• Portal Vein Reconstruction-trans Jugular Intrahepatic Portosystemic Shunt and Portal Vein Stenting in Patients With Extrahepatic Portal Vein Obstruction
• Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
• PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases
• Pre-treatment with tocilizumab reduces lipopolysaccharide-induced acute lung injury in biliary cirrhotic rats
• Predictors of portal vein thrombosis after simultaneous hepatectomy and splenectomy: A single-center retrospective study
• Primary biliary cholangitis and Sjogren's syndrome: bi-directional Mendelian randomization analysis
• Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?
• Recent Clinical Implications of FAPI: Imaging and Therapy
• Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome
• Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial
• Relationships of serum MMP-7 and clinical characteristics in choledochal cyst children
• Role of point-of-care ultrasound (POCUS) in clinical hepatology
• Role of splenic hepatic elastography ratio in differentiating non-cirrhotic portal fibrosis and chronic liver disease in children and adolescents
• Rosacea and autoimmune liver diseases: a two-sample Mendelian randomization study
• Seladelpar as an alternate second line agent for Primary Biliary Cirrhosis
• Seladelpar as an Alternate Second-Line Agent for Primary Biliary Cirrhosis
• Signalling of the neuropeptide calcitonin gene-related peptide (CGRP) through RAMP1 promotes liver fibrosis via TGFbeta1/Smad2 and YAP pathways
• Systematic review of the mechanism and assessment of liver fibrosis in biliary atresia
• The Autoimmune Gender Gap: A Rare Case of a Male Patient With Overlapping Autoimmune Hepatitis and Primary Biliary Cholangitis
• The building of an institutional liver transplant registry: opportunities and challenges
• The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC
• The impact of hepatic and splenic volumetric assessment in imaging for chronic liver disease: a narrative review
• The new definition of dominant stricture in primary sclerosing cholangitis: Prevalence and clinical significance
• The overlap with metabolic dysfunction-associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis
• The potential and pitfalls of using a large language model such as ChatGPT, GPT-4, or LLaMA as a clinical assistant
• The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis
• The treatment of primary biliary cholangitis: from shadow to light
• Trends of autoimmune liver disease inpatient hospitalization and mortality from 2011 to 2017: A United States nationwide analysis
• Unveiling Neglected Concerns: Possible Severe Hepatic Complications after Nephrectomy in Autosomal Dominant Polycystic Kidney Disease - A Case Report
• Why are rare diseases underdiagnosed? A clinical management study on detection of primary biliary cholangitis in primary care